Hematology Case Conference: "Critical appraisal of the ANNEXA-I randomized controlled clinical trial" (Anand Kornepati, MD, PhD, 1st Yr Fellow)
Anand Kornepati, MD, PhD, 1st Yr Hem/Onc Fellow
to
Hematology Case Conference: “Beefcake 5000: Has access to the fountain of Youth been restored” Ammon Fager, MD (Hematology Faculty)
Ammon Fager, MD, PhD (Assistant Professor of Medicine, Division of Hematology, Duke University)
to
Clinical Risk Prediction Modeling with Machine Learning and AI
Andrew Olson
to
_20250723110000PM.png)
Biomechanical Path to Osteoarthritis Following Knee Injury and a GAIT-way to Improved Outcomes
Brian Pietrosimone, PhD, ATC
to
Hematology Case Conference: "VTE Risk with Estrogen-Gender Affirming Hormone Therapy: An Institutional Experience at the Duke Gender Clinic"Sargam Kapoor, MD (Assistant Professor)
Sargam Kapoor, MD (Assistant Professor of Medicine, Division of Hematology, Duke University)
to
Hematology Case Conference: “The Hematology T32 Training Program: Next Step” (Gowthami M. Arepally, MD, Professor of Medicine, Division of Hematology)
Gowthami M. Arepally, MD (Professor of Medicine, Division of Hematology, Duke University)
to
Hematology Case Conference:
Kristen McClellan, MD (1st Yr Fellow, Hematology/Oncology, Duke University Medical Center)
to
Hematology Case Conference: “Prefibrotic Myelofibrosis: The Middle Child” Sandy El Bitar, MD (Asst. Professor of Medicine, Div. of Hematology)
Sandy El Bitar, MD (Assistant Professor of Medicine, Division of Hematology)
to
Hematology Case Conference: "Peculiar travel suggestions are dancing lessons from God" Ara Metjian, MD (Hematology Faculty)
Ara Metjian, MD (Instructor in the Department of Medicine, Division of Hematology, Duke University)
to